Company
Akero Therapeutics
Akero Therapeutics has 2 drugs tracked on RxWires: 1 in Phase 3, 1 in Phase 2.
Pipeline
| Drug | Phase | Indication |
|---|---|---|
| Efruxifermin | Phase 3 | NASH/MASH |
| EFX | Phase 2 | NASH - Nonalcoholic Steatohepatitis |
Latest
No recent events.
Follow Akero Therapeutics on RxWires to get trial status changes, FDA actions, filings and patent dates as they happen.
Sourced from ClinicalTrials.gov, openFDA, SEC EDGAR and the FDA Orange Book. Not investment or medical advice.